IM Cannabis Corp. (IMCC)
1.36
+0.03
(+2.26%)
USD |
NASDAQ |
Oct 16, 09:54
IM Cannabis Profit Margin (Quarterly) : -57.78% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -57.78% |
| March 31, 2026 | -28.43% |
| December 31, 2025 | -50.15% |
| September 30, 2025 | -27.90% |
| June 30, 2025 | -1.53% |
| March 31, 2025 | 1.40% |
| December 31, 2024 | -9.10% |
| September 30, 2024 | -7.79% |
| June 30, 2024 | -23.43% |
| March 31, 2024 | -49.90% |
| December 31, 2023 | -32.90% |
| September 30, 2023 | -17.27% |
| June 30, 2023 | -28.06% |
| Date | Value |
|---|---|
| March 31, 2023 | -6.91% |
| December 31, 2022 | -66.74% |
| September 30, 2022 | -31.98% |
| June 30, 2022 | -29.14% |
| March 31, 2022 | -45.57% |
| December 31, 2021 | -84.35% |
| September 30, 2021 | 10.32% |
| June 30, 2021 | -45.80% |
| March 31, 2021 | 53.78% |
| December 31, 2020 | -407.7% |
| September 30, 2020 | 12.52% |
| June 30, 2020 | -258.1% |
| March 31, 2020 | 14.93% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| InterCure Ltd. | -- |
| Teva Pharmaceutical Industries Ltd. | -13.88% |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | -239.1% |
| Purple Biotech Ltd. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -56.13% |
| Return on Invested Capital | -128.4% |
| Gross Profit Margin (Quarterly) | 19.83% |
| Operating Margin (Quarterly) | -27.54% |
| Return on Net Operating Assets | -78.08% |